R A Toillon - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

Endocrine-Related Cancer|September 17, 2004

Stable 'portrait' of breast tumors during progression: data from biology, pathology and geneticsM Lacroix, R-A Toillon, G Leclercq

Breast Cancer Research and Treatment|August 10, 2000

Autocrine and paracrine growth inhibitors of breast cancer cellsX L Bourhis, R A Toillon, B Boilly, et al.

Breast Cancer Research and Treatment|December 1, 2005

Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive yearsN Magné, R-A Toillon, P Castadot, et al.

Experimental Cell Research|December 16, 1998

Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cellsV Lambrecht, X Le Bourhis, R A Toillon, et al.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2004

[Biomodulation of transcriptional factor NF-kappa B by ionizing radiation]N Magné, C Didelot, R-A Toillon, et al.

Receptors & Channels|November 8, 2001

Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channelH Ouadid-Ahidouch, X Le Bourhis, M Roudbaraki, et al.

Molecular Cell Biology Research Communications : MCBRC|October 18, 2000

Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathwayR A Toillon, E Adriaenssens, D Wouters, et al.

Bulletin Du Cancer|February 20, 2010

[Mechanisms of resistance to molecular targeted therapies in breast cancer: update and future]N Magné, C Chargari, R Conforti, et al.

Revue Medicale De Bruxelles|April 9, 2005

[A new area for radiotherapy with favourable features]N Magné, R A Toillon, E Roux, et al.

Oncogene|September 4, 2007

Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cellsC Lagadec, E Adriaenssens, R A Toillon, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

Endocrine-Related Cancer|September 17, 2004

Stable 'portrait' of breast tumors during progression: data from biology, pathology and geneticsM Lacroix, R-A Toillon, G Leclercq

Breast Cancer Research and Treatment|August 10, 2000

Autocrine and paracrine growth inhibitors of breast cancer cellsX L Bourhis, R A Toillon, B Boilly, et al.

Breast Cancer Research and Treatment|December 1, 2005

Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive yearsN Magné, R-A Toillon, P Castadot, et al.

Experimental Cell Research|December 16, 1998

Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cellsV Lambrecht, X Le Bourhis, R A Toillon, et al.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2004

[Biomodulation of transcriptional factor NF-kappa B by ionizing radiation]N Magné, C Didelot, R-A Toillon, et al.

Receptors & Channels|November 8, 2001

Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channelH Ouadid-Ahidouch, X Le Bourhis, M Roudbaraki, et al.

Molecular Cell Biology Research Communications : MCBRC|October 18, 2000

Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathwayR A Toillon, E Adriaenssens, D Wouters, et al.

Bulletin Du Cancer|February 20, 2010

[Mechanisms of resistance to molecular targeted therapies in breast cancer: update and future]N Magné, C Chargari, R Conforti, et al.

Revue Medicale De Bruxelles|April 9, 2005

[A new area for radiotherapy with favourable features]N Magné, R A Toillon, E Roux, et al.

Oncogene|September 4, 2007

Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cellsC Lagadec, E Adriaenssens, R A Toillon, et al.

Pageof 2